Don't want ads? Subscribe or login now.

Ignore Big Pharma's Faux 'Facts,' HHS Says In Kickback Clash

By Jeff Overley · April 3, 2023, 10:47 PM EDT

Drugmakers are skewing basic issues in closely watched litigation over health care kickbacks by presenting "irrelevant material" and "slanted characterizations" as undisputed facts, federal health care officials told a Virginia federal...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opposition — HHS

Case Information

Case Title

Pharmaceutical Coalition for Patient Access v. United States of America et al.

Case Number

3:22-cv-00714

Court

Virginia Eastern

Nature of Suit

Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision

Date Filed

November 09, 2022

Recent Articles By Jeff

August 27, 2025
DOJ Throws Lifeline To J&J At 3rd Circ. After $1.6B FCA Loss
August 12, 2025
Loper Bright Neutered In 6th Circ., Tenn. Tells Supreme Court
August 06, 2025
6th Circ. Rips 'Stalking Horse' Ploy In Drug Negotiation Suit
August 05, 2025
Key Opioid Theory Actually Irrelevant, Drug Cos. Tell 4th Circ.
July 25, 2025
In New Twist, W.Va. Judges Suddenly At Odds In Opioid Suits
July 23, 2025
FCA Draws Heavy Constitutional Fire After $1.6B J&J Verdict
July 03, 2025
Circuit-By-Circuit Recap: Justices Send Message To Outliers
June 12, 2025
'Forum Shopping' Center Stage At 6th Circ. Drug Pricing Args
May 02, 2025
Insulin Giants' Antitrust Victory On Shaky Ground At 2nd Circ.
February 18, 2025
1st Circ. Backs Strict View Of Kickback Law In Blow To FCA